Skip to Content
Interactive Textbook on Clinical Symptom Research Logo


Home Button

 

Clinical Research on Dyspnea
Author Bios
What is Dyspnea?
What Provokes Dyspnea?
The Nature of Dyspnea
Language of Dyspnea
Clinical Application
Research Application
Variability in Sensations
Challenges in Study
Mechanical Loads and Sense of Effort
Chemoreceptors
Mechanoreceptors
Neuro-Mechanical Dissociation
Phase of Respiration and Dyspnea
Physiology of Dyspnea
Respiratory System
Cardiovascular System
Measuring Dyspnea
Scaling Issues
Qualitative Aspects
Reliability and Validity Overview
Reliability and Validity
Sensitivity and Specificity
Scales
Sensation vs. Perception vs. Symptom
Currently selected section: Treating Dyspnea
Why Measure?
Cluster Analysis
Statistical vs. Clinical Significance
Standard Error of Measurement
Measuring Fatigue
Measuring Depression
Measuring Anxiety and Hyperventilation
Measuring Quality of Life
Conclusion

 

Chapter 23: Dyspnea: Treating Dyspnea
        

The first premise when considering treatment of a patient suffering from dyspnea is to attempt to correct the underlying medical condition causing the symptom. Many chronic respiratory conditions, such as emphysema, asthma, and pulmonary fibrosis, are not curable and, even with optimal medical therapy, may lead to persistent discomfort and morbidity. Unable to "fix the problem," physicians may be tempted to treat the symptoms, (particularly if they are quite intense) in a non-specific way, typically by using narcotics. Although narcotics may be very effective in blunting the intensity of dyspnea, they also have significant side-effects including alteration of consciousness, constipation, and suppression of respiratory drive with the potential for acute hypoxemia and hypercapnia. Faced with these dilemmas, researchers have begun to explore interventions that target specific physiological mechanisms believed responsible for dyspnea in a given condition.

Question 25.1

If the dissociation between the efferent messages from the respiratory controller and movement of the chest wall contributes to the dyspnea of COPD, how might one alleviate the respiratory discomfort in a patient with emphysema who is on maximal medical therapy?

Selection AAdminister nebulized lidocaine
Selection B Suppress the drive to breathe
Selection C Stimulate chest wall receptors

Figure 25.1: Effect of Chest Wall Vibration on Dyspnea at Rest in 15 Patients with Chronic Respiratory Disease
Data gathered in an attempt to determine if chest wall vibration would relieve dyspnea in patients, described in text.
Official Journal of the American Thoracic Society. © American Lung Association.
Reprinted with permission.

This figure shows data gathered in an attempt to determine if chest wall vibration would relieve dyspnea in patients. In-phase chest wall vibration reduced dyspnea at rest in patients with COPD. A subsequent study in patients with COPD, however, showed no effect of chest wall vibration on dyspnea during exercise although the dyspnea associated with acute hypercapnia was ameliorated (Cristiano and Schwartzstein, 1997). The difference in the results among these studies may be due, in part, to the more intense discomfort during exercise in the latter investigation. The effect of chest wall vibration may be small and could be overwhelmed by the rapidly rising discomfort during exercise.

The sequence of studies outlined above demonstrates how researchers are beginning to approach interventions to reduce dyspnea based on knowledge of specific physiological mechanisms underlying the uncomfortable sensations. Initially, studies are designed specifically to assess the intensity of dyspnea. Of course, for a therapeutic intervention to become widely accepted, additional outcomes, such as quality of life of the patients, will also need to be addressed.

Page 36 of 47
      Previous Section